ArticleBlood advances2020

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

Zheng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.